CoBX Bio
PrivateLast Round
Pre Seed
Sep 3, 2025
Total Funding Raised
$5.55M
Company Overview
CoBX Bio operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Pre Seed round in September 2025.
CoBX Bio, Inc. is a pharmaceuticals company that researches and develops covalent bond inhibitors and molecular adhesive degraders to address shortcomings of current synthetic medications.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CoBX Bio Comparables
Compare CoBX Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pin Therapeutics | 80% | |
| Protai | 79% | |
| Monte Rosa Therapeutics | 76% |
For institutional investors. Book with your work email.
CoBX Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
CoBX Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UTC Investment | Pre Seed |
| Korea Investment Partners | Pre Seed |
| KB Investment | Pre Seed |
| Company K Partners | Pre Seed |
| Laplace Partners | Pre Seed |
| Solidus Investment | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 3, 2025
$5.55M raised from UTC Investment and Company K Partners.
For institutional investors. Book with your work email.
CoBX Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CoBX Bio's valuation, stock price, and market status.
Is CoBX Bio a public or private company?
CoBX Bio is a private company.
What is the current stock price of CoBX Bio?
CoBX Bio is a private company, so its shares have no public market price. Caplight tracks CoBX Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CoBX Bio worth (valuation)?
Valuation information for CoBX Bio is not publicly available.
Can I buy CoBX Bio stock?
CoBX Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CoBX Bio's last funding round?
CoBX Bio's most recent funding round was Pre Seed on September 3, 2025.
Who are the main investors in CoBX Bio?
Key investors in CoBX Bio include UTC Investment, Korea Investment Partners, KB Investment, Company K Partners, Laplace Partners.
Will CoBX Bio IPO soon?
No public IPO plans have been announced for CoBX Bio.
How can I track CoBX Bio secondary market activity?
Caplight tracks bids, offers, and trades in CoBX Bio's shares on secondary markets.